Table 4.
Laboratory values of cancer-free patients who suffered their first stroke (group 2A) and those patients who suffered recurrent stroke (group 2B) at the time of presentation.
| Parameters | Group 2A (n = 72) | Group 2B (n = 15) | pa |
|---|---|---|---|
| BUN (mg/dl) | 17.85 ± 6.84 | 19.06 ± 7.97 | 0.545 |
| Cre (mg/dl) | 0.90 ± 0.32 | 0.87 ± 0.15 | 0.706 |
| AST (U/L) | 23.10 ± 10.74 | 23.20 ± 6.04 | 0.972 |
| ALT (U/L) | 21.79 ± 11.75 | 22.40 ± 9.37 | 0.851 |
| Hematocrit (%) | 41.69 ± 5.16 | 38.89 ± 4.90 | 0.058 |
| D.dimer (ug FEU/ml) | (0.10–11.55) | (0.10–14.40) | 0.649 |
| CRP (mg/dl) | (0.30–1.60) | (0.20–3.90) | 0.874 |
| Hemoglobin (g/dl) | 13.77 ± 1.87 | 12.83 ± 2.00 | 0.084 |
| Platelets (×103 μL) | 230.05 ± 64.38 | 249.73 ± 75.41 | 0.299 |
Group 2A, consisted of ischemic stroke patients who had one stroke; Group 2B, consisted of ischemic stroke patients who had more than one stroke. BUN, blood urine nitrogene; Cre, creatinine; AST, aspartate transaminase; ALT, alanine transaminase; CRP, c-reactive protein.
a
Chi-square test.